Buy-side quality of earnings is the institutional examination an acquirer conducts during diligence to validate or reprice reported EBITDA. It systematically tests the target's earnings across eight adjustment categories, quantifies repricing exposure, and produces the defended EBITDA range the acquirer underwrites. In upper middle market transactions, buy-side QofE typically identifies 8 to 18 percent in EBITDA adjustments.
The Letter of Intent creates a diligence window. The target has presented reported EBITDA. The acquirer has agreed to terms based on that number. Buy-side quality of earnings is the examination that determines whether that number holds — or whether the acquirer has the evidence to reprice.
The examination is not adversarial. It is the disciplined application of institutional standards to reported earnings, testing each category where EBITDA claims fail under scrutiny. The acquirer who executes rigorous buy-side QofE either validates the investment thesis and proceeds with confidence, or identifies the repricing leverage that protects acquirer economics.
This article maps the institutional framework for buy-side QofE: the eight adjustment categories acquirers examine, the repricing patterns that surface in upper middle market transactions, and the examination architecture that converts diligence findings into underwriting positions.
Buy-side quality of earnings examines whether reported EBITDA represents sustainable, transferable, and defensible earnings. The examination operates across three dimensions, and produces a defended EBITDA range — the earnings figure the acquirer underwrites rather than the figure the seller reported.
Are the reported earnings repeatable, or do they include one-time items, non-recurring events, or unsupported run-rate claims that will not recur under new ownership?
Do the reported earnings transfer with ownership change, or are they dependent on the founder, specific customer relationships, or arrangements that may not survive the transaction?
Are the reported earnings documented to the standard institutional capital requires, or do the claims lack the evidence needed to survive examination?
Institutional acquirers examine eight categories in every buy-side quality of earnings analysis. The categories are not discretionary — they are the dimensions where EBITDA claims fail under examination.
What the acquirer examines. The difference between what the owner paid themselves and what a hired replacement would cost at market rates.
Typical finding. 60 to 75 percent of sellers understate the compensation adjustment. Owners either underpay themselves, creating phantom EBITDA that disappears when a manager is hired, or overpay, creating add-back opportunity the seller may have already claimed.
What survives examination. Market compensation benchmarks supported by industry data, role-by-role replacement cost analysis, and documentation of owner duties that would transfer to hired management.
What the acquirer examines. Vehicles, travel, club memberships, family services, and other personal benefits run through the business.
Typical finding. 50 to 65 percent of sellers have incomplete documentation of personal expenses. The add-back is claimed, but the evidence that the expense is truly personal rather than business-related is insufficient.
What survives examination. Clear documentation that expenses are personal, consistent treatment year-over-year, and absence of business purpose that would make the expense recurring post-close.
What the acquirer examines. Litigation settlements, restructuring costs, one-time gains or losses, and other items claimed as non-recurring.
Typical finding. 40 to 55 percent of non-recurring claims fail the institutional standard. Items recur at some frequency, are operational in nature, or lack the documentation that establishes non-recurring status.
What survives examination. Items that are demonstrably one-time, non-operational, and documented with evidence the acquirer can verify. Non-recurring litigation that settles annually is not non-recurring.
What the acquirer examines. Claims that recently won contracts, price increases, or capacity additions create earnings that are not yet reflected in trailing financials.
Typical finding. 70 to 85 percent of run-rate claims are unsupported. The contract is not signed, the price increase is not confirmed, or the capacity addition has not produced the projected volume.
What survives examination. Signed contracts with committed volume, implemented price increases with documented customer acceptance, and capacity additions with historical evidence of demand.
What the acquirer examines. Cut-off timing, deferred revenue treatment, milestone recognition, and consistency between periods.
Typical finding. 45 to 60 percent of sellers have revenue recognition inconsistencies that inflate or deflate earnings depending on the period examined.
What survives examination. Consistent application of revenue recognition policy, clean cut-off at period end, and deferred revenue treatment that matches the economics of the underlying contracts.
What the acquirer examines. Inventory valuation, COGS methodology, gross margin consistency, and cost allocation between periods.
Typical finding. 50 to 65 percent of sellers have cost accounting volatility that affects EBITDA reliability. Inventory valuation methods vary, COGS includes items that should be below the line, or gross margin swings without operational explanation.
What survives examination. Consistent cost accounting methodology, inventory valuation that matches physical counts, and gross margin trends with operational explanations.
What the acquirer examines. Revenue share from the top customer, top five customers, and top ten customers; sustainability of key relationships; and transferability of relationships post-close.
Typical finding. Customer concentration is always examined. Top customer above 20 percent or top five above 50 percent triggers institutional scrutiny that does not disappear with good answers.
What survives examination. Documented customer relationships with evidence of stability, diversification trend over trailing periods, and transition planning that demonstrates relationships transfer with ownership.
What the acquirer examines. Normalized working capital levels, seasonality patterns, and defensibility of the proposed working capital peg.
Typical finding. 70 to 85 percent of sellers present working capital pegs that do not reflect the capital required to operate the business. The peg is based on a favorable snapshot rather than normalized levels.
What survives examination. Working capital peg based on 12 to 24 month normalized analysis, with seasonality adjustments and true-up mechanisms that protect both parties.
Select a category to see what the acquirer examines, the typical finding across upper middle market sellers, the repricing range it carries, and what survives institutional examination.
What the acquirer examines. The difference between what the owner paid themselves and what a hired replacement would cost at market rates.
Typical finding. 60 to 75 percent of sellers understate the compensation adjustment. Owners either underpay themselves, creating phantom EBITDA that disappears when a manager is hired, or overpay, creating add-back opportunity the seller may have already claimed.
What survives examination. Market compensation benchmarks supported by industry data, role-by-role replacement cost analysis, and documentation of owner duties that would transfer to hired management.
The following is an arithmetic illustration of how the eight categories compound in an upper middle market transaction. It is not a specific client engagement — it is the pattern typical of the market segment.
| Category | Reported | Finding | Adjusted |
|---|---|---|---|
| Reported EBITDA | $60.0M | — | $60.0M |
| Owner Compensation | — | ($3.0M) market replacement adjustment | $57.0M |
| Personal Expenses | — | ($1.5M) documented adjustments | $55.5M |
| Non-Recurring Items | — | ($2.0M) items failing institutional standard | $53.5M |
| Run-Rate Adjustments | — | ($4.0M) unsupported forward claims | $49.5M |
| Revenue Recognition | — | ($1.0M) cut-off adjustments | $48.5M |
| Cost Accounting | — | ($1.5M) inventory and margin adjustments | $47.0M |
| Defended EBITDA | $60.0M | ($13.0M) | $47.0M |
on a $480M transaction (24%). This is not an extreme case — it is the pattern institutional buy-side QofE surfaces consistently.
Illustrative arithmetic only — not a client engagement or a calculation for any specific company.
The examination architecture institutional acquirers deploy for buy-side quality of earnings, from data room intake through category-by-category examination, the working capital deep dive, and the synthesis that produces a defended EBITDA range.
Map available financial information against examination requirements in the first seven days, identify gaps requiring management follow-up, and establish the documentation standard findings must meet.
Execute the eight-category analysis against source documentation, build the adjustment schedule with category-by-category support, and test each proposed adjustment against the institutional standard of non-recurring, non-operational, transferable, and documented.
Analyze trailing working capital across 24 to 36 months, identify seasonality, one-time distortions, and trend changes, then build the normalized working capital model and test the proposed peg.
Build the EBITDA bridge from reported to defended, translate findings into enterprise value and equity value impact, and document the negotiation position in the buy-side QofE memorandum.
| Dimension | Sell-Side QofE | Buy-Side QofE |
|---|---|---|
| Commissioned By | Seller | Acquirer |
| Purpose | Defend EBITDA before going to market | Identify repricing exposure during diligence |
| Timing | Pre-LOI (60 to 90 days before launch) | Post-LOI (during diligence window) |
| Output | Defended EBITDA range to support asking price | Adjustment findings to support repricing |
| Narrative Control | Seller defines the story acquirers react to | Acquirer challenges the story seller presented |
| Typical Cost | $400K to $1.2M | $500K to $1.5M |
The strategic implication. The side that examines first controls the narrative. A seller who commissions sell-side QofE arrives with a defended position the acquirer must argue against. A seller who does not arrives with reported EBITDA the acquirer's examination will reprice.
Acquirers who encounter sellers with sell-side QofE should expect smaller adjustment opportunity. Acquirers who encounter sellers without sell-side QofE should expect the full 8 to 18 percent repricing range to be available.
TEOL's buy-side QofE examination applies the institutional framework with specific methodological standards.
Before examining adjustments, TEOL positions the target on the Financial Truth Ladder — the five-rung framework that reads EBITDA defensibility. A target at Rung 2 requires deeper examination than a target at Rung 4. The rung position sets examination intensity.
Every engagement examines all eight categories, even when preliminary review suggests some categories are clean. Categories that appear clean often reveal findings under examination.
Adjustments are not accepted based on management assertion. Every adjustment TEOL reports is traced to source documentation the acquirer can verify.
Working capital is not treated as a closing mechanic. TEOL integrates working capital analysis with QofE examination, because the peg is often the largest single adjustment in upper middle market transactions.
The output is not a findings list. TEOL synthesizes QofE findings into an underwriting position — defended EBITDA, enterprise value impact, and negotiation leverage — that the acquirer can act on.
Buy-side quality of earnings is not compliance verification. It is the institutional examination that validates — or reprices — the investment thesis before capital is deployed.